<DOC>
	<DOCNO>NCT02164084</DOCNO>
	<brief_summary>This study identify much ( ) drug absorb skin subject acne vulgaris topical application SB204 .</brief_summary>
	<brief_title>A 2 Period Cross-over Pharmacokinetic Study SB204 Acne Vulgaris</brief_title>
	<detailed_description>This single-center , double-blind , randomize , 2 period cross-over study conduct 18 subject ( 18 year age ) receive SB204 8 % Vehicle Gel . Subjects satisfy entry criterion randomize SB204 8 % Vehicle Gel 1:1 ratio first treatment period . Study drug apply face , upper chest , upper back shoulder ( approximately 17 % BSA ) twice daily Days 1- 4 approximately 12 hour apart . On Day 5 , study drug apply area , morning . Pharmacokinetic ( PK ) profile perform Day 1 Day 5 . After wash period , subject treat alternate product undergo similar treatment assessment . The primary assessment pharmacokinetic profile nitrate silicon marker systemic exposure nitric oxide ( nitrate ) NVN1000 ( silicon ) topical application SB204 8 % approximately 17 % total body surface area .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<criteria>Male female subject acne severity moderate severe minimum 20 inflammatory 20 noninflammatory lesion face , trunk shoulder 18 year age older Any subject skin disorder acute chronic nature include psoriasis , eczema , tinea versicolor , etc . Subjects smoke use tobacco product Subjects methemoglobin level great 2 % Screening Baseline pulse cooximeter . Subjects previous history methemoglobinemia Subjects treat nitrate drug associate methemoglobinemia Subjects know history HIV , hepatitis , bloodborne pathogen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>acne</keyword>
</DOC>